TABLE 5.
LENGTH OF THERAPY | ALL PATIENTS | FEMALE PATIENTS | MALE PATIENTS |
---|---|---|---|
1 Rx | |||
2 Rx | |||
3 Rx | |||
4 Rx | 17% | 17% | 17% |
5 Rx | 39% | 40% | 38% |
6 Rx | 26% | 26% | 27% |
7 Rx | 10% | 10% | 10% |
8+ Rx | 8% | 7% | 8% |
TOTAL | 28,840 | 15,656 | 13,182 |
A total of 44% of all patients went beyond the FDA-recommended maximum of 5 months duration of treatment 43% females; 45% for males